Pacira BioSciences Inc PCRX

NAS: PCRX | ISIN: US6951271005 15:48

30,27 USD (-1,80%)

(-1,80%) 15:48

Grafiek Pacira BioSciences Inc

Grafiek Pacira BioSciences Inc

1 dag1d -1,80%
1 week1w -0,38%
1 maand1m 15,96%
3 maanden3m 1,36%
6 maanden6m 9,38%
1 jaar1j -27,00%
5 jaar5j -30,14%

Pacira BioSciences Inc in het nieuws

Toon enkel gratis nieuws

1 februari 2024 · G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams · Persbericht

17 november 2022 · New Research Reveals Common Treatments for Knee Pain are Falling Short, Placing Physical, Social, and Mental Burden on Patients · Persbericht

16 juni 2022 · National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse · Persbericht

25 mei 2022 · Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze Dance · Persbericht

20 april 2021 · Spine BioPharma Announces Investment by Pacira Biosciences · Persbericht

9 maart 2021 · Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021 · Persbericht

3 maart 2021 · Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference · Persbericht

18 februari 2021 · Pacira to Report 2020 Financial Results on Thursday February 25, 2021 · Persbericht

10 februari 2021 · Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021 · Persbericht

6 januari 2021 · Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Pacira BioSciences Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Hoofdzetel: Parsippany, New Jersey Verenigde Staten

CEO: David M. Stack

Werknemers: 778

Aandelen Pacira BioSciences Inc

Beurswaarde: 1,43 miljard USD

Effecten: 46,55 miljoen

Winst per aandeel (12 maand): PLUS

Koers-winstverhouding: PLUS

Beta: 0,49

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe